To investigate the specificity of the ELISA assays we included 54 serum samples that were collected before the COVID‐19 pandemic or from patients testing negative for COVID‐19 but confirmed with other bacterial, viral infections or autoimmune diseases. These samples had been stored frozen at −70°C. The samples included sera testing positive for Epstein‐Barr virus (n = 1), Cytomegalovirus (n = 4), Influenza A (n = 5), Influenza B (n = 6), Parainfluenza virus (n = 9), Mycoplasma pneumoniae (n = 3), Respiratory syncytial virus (n = 3), Borrelia burgdorferi (n = 6), Human granulocytic anaplasmosis (HGA) (n = 3), Treponema pallidum (n = 1), Rheumatoid arthritis (n = 3), Systemic lupus erythematosus (n = 1). Additionally, nine sera samples were obtained from patients with PCR‐confirmed human coronavirus infections, not SARS‐CoV‐2.

注意:以上内容是从某篇研究文章中自动提取的,可能无法正确显示。



Q&A
请登录并在线提交您的问题
您的问题将发布在Bio-101网站上。我们会将您的问题发送给本研究方案的作者和具有相关研究经验的Bio-protocol成员。我们将通过您的Bio-protocol帐户绑定邮箱进行消息通知。